The impact of no-reflow phenomena after primary percutaneous coronary intervention: A time-dependent analysis of mortality

Coronary Artery Disease

Volumn 25, Issue 5, 2014, Pages 392-398

  Choo, Eun Ho ^a   Kim, Pum Joon ^a   Chang, Kiyuk ^a   Ahn, Youngkeun ⁱ   Jeon, Doo Soo ^c   Lee, Jong Min ^d   Kim, Dong Bin ^b   Her, Sung Ho ^e   Park, Chul Soo ^f   Kim, Hee Yeol ^g   Yoo, Ki Dong ^h   Jeong, Myung Ho ⁱ   Seung, Ki Bae ^a  

^a The Catholic University of Korea   (South Korea)

^b St Paul's Hospital   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Uijeongbu St Mary's Hospital   (South Korea)

^e Daejeon St Mary's Hospital   (South Korea)

^f The Catholic University of Korea   (South Korea)

^g The Catholic University of Korea   (South Korea)

^h The Catholic University of Korea   (South Korea)

ⁱ Chonnam National University Medical School   (South Korea)

Author keywords

acute myocardial infarction; drug eluting stent; mortality; no reflow; percutaneous coronary intervention

Indexed keywords

ADULT; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR MORTALITY; DISEASE REGISTRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SOUTH KOREA; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ADVERSE EFFECTS; AGED; ANGIOCARDIOGRAPHY; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; DEVICES; DRUG ELUTING STENT; KAPLAN MEIER METHOD; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

AGED; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84904059800     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0000000000000108     Document Type: Article

References (15)

1. Kloner RA, Ganote CE, Jennings RB. The no-reflow phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974; 54:1496-1508.
2. Brosh D, Assali AR, Mager A, Porter A, Hasdai D, Teplitsky I, et al. Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. Am J Cardiol 2007; 99:442-445.
3. Bolognese L, Carrabba N, Parodi G, Santoro GM, Buonamici P, Cerisano G, Antoniucci D. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 2004; 109:1121-1126.
4. Sorajja P, Gersh BJ, Costantini C, McLaughlin MG, Zimetbaum P, Cox DA, et al. Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction. Eur Heart J 2005; 26:667-674.
5. Ndrepepa G, Tiroch K, Fusaro M, Keta D, Seyfarth M, Byrne RA, et al. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 2010; 55:2383-2389.
6. Valgimigli M, Campo G, Malagutti P, Anselmi M, Bolognese L, Ribichini F, et al. Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the strategy (single high-dose bolus tirofiban and sirolimus-eluting stent versus abciximab and bare-metal stent in acute myocardial infarction) and multistrategy (multicenter evaluation of single high-dose bolus tirofiban versus abciximab with sirolimus-eluting stent or bare-metal stent in acute myocardial infarction study) trials. JACC Cardiovasc Interv 2011; 4:51-62.
7. Svilaas T, Vlaar PJ, van der Horst IC, Diercks GF, de Smet BJ, van den Heuvel AF, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008; 358:557-567.
8. Harrison RW, Aggarwal A, Ou FS, Klein LW, Rumsfeld JS, Roe MT, Wang TY. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am J Cardiol 2013; 111:178-184.
9. Schwartz BG, Kloner RA. Coronary no reflow. J Mol Cell Cardiol 2012; 52:873-882.
10. Wang JW, Chen YD, Wang CH, Yang XC, Zhu XL, Zhou ZQ. Development and validation of a clinical risk score predicting the no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Cardiology 2013; 124: 153-160.
11. Yip HK, Chen MC, Chang HW, Hang CL, Hsieh YK, Fang CY, Wu CJ. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and noreflow phenomenon. Chest 2002; 122:1322-1332.
12. Jaffe R, Charron T, Puley G, Dick A, Strauss BH. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation 2008; 117:3152-3156.
13. Magro M, Nauta ST, Simsek C, Boersma E, van der Heide E, Regar E, et al. Usefulness of the syntax score to predict no reflow in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am J Cardiol 2012; 109:601-606.
14. Morishima I, Sone T, Mokuno S, Taga S, Shimauchi A, Oki Y, et al. Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty. Am Heart J 1995; 130:239-243.
15. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of st-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2013; 61:e78-e140.